{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:32:08Z","timestamp":1761561128521},"reference-count":56,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T00:00:00Z","timestamp":1134345600000},"content-version":"vor","delay-in-days":3208,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1997,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective.<\/jats:italic> To evaluate the in vitro effects of 4 antiinflammatory and 5 immunosuppressive agents on the release of preformed and de novo\u2010synthesized mediators from human synovial mast cells (HSyMC) activated by immunologic and nonimmunologic stimuli.<\/jats:p><jats:p><jats:italic>Methods.<\/jats:italic> The effects of antiinflammatory and immunosuppressive agents were evaluated on the in vitro release of histamine and tryptase and the de novo synthesis of prostaglandin D<jats:sub>2<\/jats:sub> (PGD<jats:sub>2<\/jats:sub>) and leukotriene C<jats:sub>4<\/jats:sub> (LTC<jats:sub>4<\/jats:sub>) by HSyMC challenged with anti\u2010IgE and substance P.<\/jats:p><jats:p><jats:italic>Results.<\/jats:italic> Nimesulide, a sulfonanilide nonsteroidal antiinflammatory drug (NSAID) chemically unrelated to other acidic NSAIDs (such as acetylsalicylic acid [ASA], diclofenac, and piroxicam) inhibited in a concentration\u2010dependent manner the release of preformed (histamine and tryptase) mediators from HSyMC challenged with anti\u2010IgE. In contrast, diclofenac and piroxicam had little or no effect on HSyMC activated by anti\u2010IgE. ASA, diclofenac, piroxicam, and nimesulide caused a concentration\u2010dependent inhibition of IgE\u2010mediated PGD<jats:sub>2<\/jats:sub> release from HSyMC. Nimesulide, but not diclofenac or piroxicam, also inhibited the de novo synthesis of LTC<jats:sub>4<\/jats:sub> by HSyMC challenged with anti\u2010IgE. Nimesulide, diclofenac, and piroxicam had no effect on HSyMC activated by substance P. Cyclosporin A (CSA) inhibited histamine release from HSyMC challenged with anti\u2010IgE, whereas cyclosporin H (CSH) had no effect. FK\u2010506 also inhibited histamine release from HSyMC activated by anti\u2010IgE, whereas rapamycin had no effect. Neither CSA, CSH, FK\u2010506, nor rapamycin inhibited the release of histamine from HSyMC induced by substance P. Methotrexate had no effect on the release of mediators from these cells, whereas adenosine (<jats:italic>R<\/jats:italic>\u2010phenylisopropyl adenosine and 5\u2010<jats:italic>N<\/jats:italic>\u2010ethylcarboxamide adenosine) enhanced histamine release from immunologically activated HSyMC in a concentration\u2010dependent manner.<\/jats:p><jats:p><jats:italic>Conclusion.<\/jats:italic> Mast cells isolated from human synovia display 4 levels of pharmacologic heterogeneity with regard to 1) the inhibitory effects of 4 antiinflammatory drugs; 2) the capacity of different immunosuppressive drugs to exert antiinflammatory activity; 3) the inhibition of the release of different mediators; and 4) the capacity of antiinflammatory and immunosuppressive drugs to modulate HSyMC activated by different stimuli. This complexity of pharmacologic modulation of HSyMC in vitro might help explain the different activity of the compounds used to treat various pathophysiologic aspects of the inflammatory arthritides.<\/jats:p>","DOI":"10.1002\/art.1780400313","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T12:49:52Z","timestamp":1171457392000},"page":"469-478","source":"Crossref","is-referenced-by-count":35,"title":["Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs"],"prefix":"10.1002","volume":"40","author":[{"given":"Amato","family":"de Paulis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ciccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Marin\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"de Crescenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Marin\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Marone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,12]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270803"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290803"},{"key":"e_1_2_1_4_2","first-page":"120","article-title":"Activation of rheumatoid synovial mast cells: role of IgE\u2010associated antiglobulins","volume":"26","author":"Gruber B","year":"1989","journal-title":"Monogr Allergy"},{"key":"e_1_2_1_5_2","volume-title":"Human Basophils and Mast Cells: Clinical Aspects","author":"Arnason JA","year":"1995"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290802"},{"key":"e_1_2_1_7_2","first-page":"1326","article-title":"Characterization of human synovial mast cells","volume":"15","author":"Kopicky\u2010Burd JA","year":"1988","journal-title":"J Rheumatol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340907"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02263503"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390723"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.146.7.2374","article-title":"FK\u2010506, a potent novel inhibitor of the release of proinflammatory mediators from human FceRI+ cells","volume":"146","author":"De Paulis A","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.4049\/jimmunol.154.6.2855","article-title":"Human heart mast cells: isolation, purification, and immunologic characterization","volume":"154","author":"Patella V","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(74)90093-1"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V85.5.1272.bloodjournal8551272","article-title":"The antineoplastic bryostatins affect human basophils and mast cells differently","volume":"85","author":"Patella V","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199211000-00016"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199106000-00016"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.4049\/jimmunol.139.9.3062","article-title":"Purification and characterization of human skin mast cells: evidence for human mast cell heterogeneity","volume":"139","author":"Lawrence ID","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.144.10.3891"},{"key":"e_1_2_1_19_2","volume-title":"Statistics for Health Professionals","author":"Schefler WC","year":"1984"},{"key":"e_1_2_1_20_2","volume-title":"The Pharmacological Basis of Therapeutics","author":"Insel PA","year":"1996"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106133242407"},{"key":"e_1_2_1_22_2","first-page":"132","article-title":"4\u2010Nitro\u20102\u2010phenoxymethane sulfonanilide (R\u2010805): a chemically novel anti\u2010inflammatory agent","volume":"222","author":"Swingle KF","year":"1976","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198836060-00004"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00613526"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609964"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(72)90470-6"},{"key":"e_1_2_1_27_2","first-page":"587","article-title":"Preclinical pharmacological studies with nimesulide","volume":"10","author":"Swingle KF","year":"1984","journal-title":"Drugs Exp Clin Res"},{"key":"e_1_2_1_28_2","first-page":"209","article-title":"Isoproterenol\u2010induced inhibition of immunoglobulin E\u2010mediated release of histamine and arachidonic acid metabolites from the human lung mast cell","volume":"247","author":"Undem BJ","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780361017"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80240-4"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780300102"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780371015"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390618"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.125.4.507"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3749892"},{"key":"e_1_2_1_36_2","volume-title":"Cyclosporin in Autoimmune Diseases","author":"Keown PA","year":"1985"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.10.5563"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","article-title":"Novel immunosuppressive agent, FK\u2010506: in vitro effects on cloned T cell activation","volume":"139","author":"Sawada S","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830201017"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1139\/v80-090"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.144.1.251"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.23.9231"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(88)90008-6"},{"key":"e_1_2_1_44_2","first-page":"1125","article-title":"Rapamycin, a potential disease\u2010modifying antiarthritic drug","volume":"266","author":"Carlson RP","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198908000-00002"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198503283121303"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116884"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(89)90513-4"},{"key":"e_1_2_1_49_2","doi-asserted-by":"crossref","first-page":"843s","DOI":"10.4049\/jimmunol.135.2.843","article-title":"The contribution of neurogenic inflammation in experimental arthritis","volume":"135","author":"Levine JD","year":"1985","journal-title":"J Immunol"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2433770"},{"key":"e_1_2_1_51_2","first-page":"1375","article-title":"Nimesulide, a sulfonanilide nonsteroidal anti\u2010inflammatory drug, inhibits mediator release from human basophils and mast cells","volume":"267","author":"Casolaro V","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340206"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/357695a0"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70237-3"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.154.4.1846"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/377441a0"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/138.5.1143"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780400313","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780400313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T21:05:35Z","timestamp":1700773535000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780400313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["10.1002\/art.1780400313"],"URL":"https:\/\/doi.org\/10.1002\/art.1780400313","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}